1)- Shivshankar Thanigaimani, James Phie, Frank Quigley, Michael Bourke, Bernie Bourke, Ramesh Velu, Jason Jenkins, Jonathan Golledge. Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth.JVS-vascular science. 2022, 3: 306-313
2)- Jan H Lindeman. Modest but impactful: Commentary on immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth.JVS-vascular science. 2022, 3: 314-315
3)- Jeffrey T Jensen, Philberta Leung, Mackenzie Roberts, Jian Guo, Shan Yao, Emily Mishler, Tanner Grenz, James Hodovan, Ov D Slayden, Jonathan R Lindner. Systemic polidocanol from intravenous or pressurized intrauterine administration produces reversible cardiovascular toxicity.JVS-vascular science. 2022, 3: 316-335
4)- Katharine G Wolf, Emily B Crawford, Nora M Wartan, Sylvia K Schneiderman, Valerie E Riehl, Svetlana V Dambaeva, Kenneth D Beaman. Ephrin-B2-expressing natural killer cells induce angiogenesis.JVS-vascular science. 2022, 3: 336-344
7)- Elise DeRoo, Mitri Khoury, Ting Zhou, Huan Yang, Amelia Stranz, Catherine Luke, Peter Henke, Bo Liu. Investigating the role of receptor interacting protein kinase 3 in venous thrombosis.JVS-vascular science. 2022, 3: 365-378
8)- Tiffany R Bellomo, Noah L Tsao, Hillary Johnston-Cox, Kamil Borkowski, Gabrielle Shakt, Renae Judy, Jonni Moore, Sarah J Ractcliffe, Oliver Fiehn, Thomas F Floyd, Felix W Wehrli, Emile Mohler, John W Newman, Scott M Damrauer. Metabolite patterns associated with individual response to supervised exercise therapy in patients with intermittent claudication.JVS-vascular science. 2022, 3: 379-388
9)- Eric J Carlson, Megan Rushkin, Derek Darby, Trisha Chau, Renee L Shirley, Jeff S King, Khanh Nguyen, Gregory J Landry, Gregory L Moneta, Cherrie Abraham, Lynn Y Sakai, Amir F Azarbal. Circulating fibrillin fragment concentrations in patients with and without aortic pathology.JVS-vascular science. 2022, 3: 389-402